Prevention of ovarian hyperstimulation syndrome: novel strategies

J.G. Grudzinskas, P.E. Egbase

In: Human Reproduction · 1998 · vol. 13(8) , pp. 2051–2053 · doi:10.1093/humrep/13.8.2051 · PMID:9756266 · W2118109406

review OA: bronze CC0

📄 Open PDF View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-12 ⓘ

This paper reviews novel strategies for preventing ovarian hyperstimulation syndrome.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (26)

Development, pharmacology and clinical experience with clomiphene citrate via openalex
Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer. via openalex
W1966835869 via openalex
W1987174978 via openalex
W1993203355 via openalex
W2017112165 via openalex
W2024453524 via openalex
W2055081871 via openalex
W2069702134 via openalex
W2095680878 via openalex
W2106543279 via openalex
W2111069923 via openalex
W2130095185 via openalex
W2174217564 via openalex
W2228961806 via openalex
W2369096602 via openalex
W2397710815 via openalex
W2481738770 via openalex
W2613689619 via openalex
W2731454925 via openalex
W4234850556 via openalex
W4247303091 via openalex
W4252703858 via openalex
W141627978 via openalex
W4285719527 via openalex
W1913663869 via openalex

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00

License: CC0 · commercial use OK